Manager TitleAgeSince
Chief Executive Officer - 04/02/2025
Director of Finance/CFO - -
Chief Operating Officer 56 01/01/2016
Director TitleAgeSince
Chairman 59 01/07/2017
Director/Board Member 48 01/01/2019
Director/Board Member 70 01/01/2017
Change 5-day change 1-year change 3-year change Capi.($)
-1.79%-1.79% - - 3.79M
-1.64%-2.19%-34.79%+34.12% 481B
-4.67%-7.25%-41.49%+81.20% 299B
-0.52%-1.63%-28.43%+48.14% 144B
-3.67%-3.10%-30.68%+218.07% 105B
+7.04%-0.92%+398.38%+2,421.03% 102B
+0.17%-2.33%+30.84%+17.18% 98B
+0.17%+0.66%-37.03%+24.28% 86.88B
-0.83%-4.46%-27.27%+143.64% 83.6B
-0.29%-1.47%-41.14%+12.52% 32.67B
Average -0.60%-1.59%+20.93%+333.35% 159.08B
Weighted average by Cap. -1.38%-2.50%+0.37%+233.59%
Logo Centogene N.V.
Crown LiquidationCo NV in liquidatie, is a commercial company. The company focuses on rare diseases, transforming clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The company's platform includes epidemiological, phenotypic, and genetic data reflecting a global population, as well as a biobank of blood samples from these patients. The company's pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. The Company's Clinical Diagnostics segment provides targeted genetic sequencing and diagnostic services to patients through its distribution partners and customers, which are typically physicians, laboratories or hospitals.
Employees
384
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!